Fortis Healthcare Share Price

Fortis Healthcare Ltd is a leading healthcare services provider in India. The company operates a chain of hospitals. The company runs a network of super speciality hospitals and multi speciality hospitals. The company offers tele-medicine services through its hospital network. It also focuses on research in various disciplines of medical science.

The company is a subsidiary of IHH Healthcare Berhad Company. It is a for-profit hospital chain and has its headquarters in Gurugram, Haryana. The first ever Fortis Hospital was established in Mohali, Punjab. Fortis provides a wide range of consolidated healthcare services including clinical care, quaternary care along with a full spectrum of ancillary services.

The market capitalisation of Fortis Healthcare Limited stood at over ₹32,800 crore, as of February 5, 2024. Fortis Healthcare share price has surged 160% in the last three years.

Fortis Healthcare business operations

The company operates 28 healthcare facilities with more than 4500 operational beds. It also operates more than 400 diagnosis centres (inclusive of Joint Ventures), which makes it one of the biggest players in the healthcare industry in India.

Outside India the company has a presence in Nepal, the United Arab Emirates (UAE) and Sri Lanka. Fortis Healthcare has partnerships with major global healthcare chains. Approximately 23,000 people are employed at Fortis.

The Fortis Memorial Research Institute (FMRI) is the flagship hospital of the company and a prominent research centre. The vision of the company is to develop an international level healthcare delivery system in the country that entails the best medical skills along with solicitous patient care. The company aims to be an internationally acclaimed organisation for healthcare excellence and distinguished patient care.

In April 2023, Fortis Healthcare Limited acquired Medeor Hospitals in Manesar, Haryana. The acquisition would enable the company to expand its presence in Gurugram where the company operates the Fortis Memorial Research Institute (FMRI).

In its earlier years, the chain had also purchased the Escorts Group’s healthcare branch which helped it increase its strength in different parts of the country.

The company’s diagnostic service arm was renamed as Agilus Diagnostics Limited with effect from May 31, 2023. Agilus has presence in 27 states and Union Territories across India. It also has centres in Nepal, outside India.

Financial highlights

• The company’s consolidated revenue from operations stood at ₹6,298 crore in FY23 as compared to ₹5,718 crore in FY22.
• Its EBITDA (earnings before interest, tax, depreciation and amortisation) stood at ₹1,101 crore in FY23 as against ₹1,096 crore in FY22.
• Its net profit for FY23 dropped to ₹633 crore compared to ₹790 crore in FY22.
• The company’s earnings per share (EPS) stood at ₹1.27 in FY23 as against ₹(-0.18) in FY22.

11 September 2025 – Fortis Healthcare Share Price Update

As of last trading day, Fortis Healthcare opened at ₹956.60 and last traded at ₹967.15, showing a rise of 17.55 points (1.85%) compared to the previous close of ₹949.60. During the session, the stock touched a high of ₹968.90 and a low of ₹948.05. The company's market capitalization now stands at ₹71,691 Crs, with a P/E ratio of 82.5 and a dividend yield of 0.14%.